SXT · Sensient Technologies Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $435.83M | - | $412.11M | $414.23M | $392.32M | - | $392.61M | $403.52M | $384.67M | - |
| Cost of Revenue | $283.15M | - | $270.77M | $271.40M | $260.55M | - | $262.21M | $272.80M | $258.12M | - |
| Gross Profit | $152.69M | - | $141.34M | $142.83M | $131.78M | - | $130.40M | $130.72M | $126.55M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $85.96M | - | $83.64M | $85.13M | $78.25M | - | $79.88M | $81.06M | $77.14M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $15.54M | - | $15.46M | $15.02M | $15.07M | - | - | - | $14.71M | - |
| Operating Income | $66.73M | - | $57.71M | $57.71M | $53.53M | - | $50.52M | $49.66M | $49.41M | - |
| Interest Expense | $7.90M | - | $7.33M | $7.39M | $7.34M | - | $7.70M | $7.65M | $7.04M | - |
| Income Tax | $14.66M | - | $13.42M | $12.73M | $11.73M | - | $10.13M | $11.07M | $11.42M | - |
| Net Income | $44.17M | - | $36.96M | $37.59M | $34.46M | - | $32.69M | $30.93M | $30.94M | - |
| EPS - Basic | $1.04 | - | $0.87 | $0.89 | $0.82 | - | $0.78 | $0.73 | $0.73 | - |
| EPS - Diluted | $1.04 | - | $0.87 | $0.88 | $0.81 | - | $0.77 | $0.73 | $0.73 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38.54M | $36.53M | $42.67M | $56.69M | $32.57M | $26.63M | $36.97M | $30.34M | $25.42M | $28.93M |
| Accounts Receivable | $342.30M | $305.38M | $323.39M | $333.95M | $315.02M | $290.09M | $302.01M | $315.60M | $298.49M | $272.16M |
| Inventory | $681.73M | $678.22M | $653.72M | $619.60M | $598.20M | $600.30M | $580.85M | $553.41M | $568.55M | $598.40M |
| Accounts Payable | $114.22M | $138.34M | $122.88M | $121.44M | $110.61M | $139.05M | $119.24M | $107.22M | $104.83M | $131.11M |
| Current Assets | $1.12B | $1.08B | $1.07B | $1.07B | $1.00B | $961.89M | $958.80M | $944.25M | $942.84M | $936.62M |
| Total Assets | $2.29B | $2.24B | $2.21B | $2.20B | $2.09B | $2.02B | $2.04B | $1.99B | $2.01B | $2.01B |
| Current Liabilities | $223.71M | $263.58M | $233.69M | $251.12M | $230.69M | $270.64M | $256.45M | $227.03M | $218.86M | $236.31M |
| Long-term Debt | $767.56M | $709.23M | $711.18M | $710.12M | $683.27M | $613.52M | $625.63M | $634.66M | $643.51M | $645.09M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $1.22B | $1.19B | $1.18B | $1.16B | $1.10B | $1.06B | $1.08B | $1.06B | $1.06B | $1.05B |
| Retained Earnings | $1.87B | $1.85B | $1.84B | $1.82B | $1.80B | $1.78B | $1.77B | $1.75B | $1.74B | $1.73B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($13.62M) | - | - | - | ($8.98M) | - | - | - | $15.13M | - |
| Investing Cash Flow | ($26.92M) | - | - | - | ($21.28M) | - | - | - | ($10.94M) | - |
| Financing Cash Flow | $42.40M | - | - | - | $35.96M | - | - | - | ($9.12M) | - |
| CapEx | $28.74M | - | - | - | $16.85M | - | - | - | $11.03M | - |
| Free Cash Flow | ($42.35M) | - | - | - | ($25.83M) | - | - | - | $4.10M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 35.0% | - | 34.3% | 34.5% | 33.6% | - | 33.2% | 32.4% | 32.9% | - |
| Operating margin | 15.3% | - | 14.0% | 13.9% | 13.6% | - | 12.9% | 12.3% | 12.8% | - |
| EBITDA margin | 18.9% | - | 17.8% | 17.6% | 17.5% | - | - | - | 16.7% | - |
| Net margin | 10.1% | - | 9.0% | 9.1% | 8.8% | - | 8.3% | 7.7% | 8.0% | - |
| Free cash flow margin | -9.7% | - | - | - | -6.6% | - | - | - | 1.1% | - |
| FCF / Net income | -0.96 | - | - | - | -0.75 | - | - | - | 0.13 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 19.7% | - | 20.3% | 20.6% | 19.9% | - | 20.3% | 20.1% | 20.1% | - |
| Effective tax rate | 24.9% | - | 26.6% | 25.3% | 25.4% | - | 23.7% | 26.4% | 27.0% | - |
| Return on assets | 1.9% | - | 1.7% | 1.7% | 1.6% | - | 1.6% | 1.6% | 1.5% | - |
| Return on equity | 3.6% | - | 3.1% | 3.2% | 3.1% | - | 3.0% | 2.9% | 2.9% | - |
| Return on invested capital | 2.5% | - | 2.2% | 2.3% | 2.2% | - | 2.3% | 2.2% | 2.1% | - |
| Liquidity | ||||||||||
| Current ratio | 5.01 | 4.10 | 4.59 | 4.25 | 4.34 | 3.55 | 3.74 | 4.16 | 4.31 | 3.96 |
| Quick ratio | 1.97 | 1.53 | 1.79 | 1.78 | 1.74 | 1.34 | 1.47 | 1.72 | 1.71 | 1.43 |
| Cash ratio | 0.17 | 0.14 | 0.18 | 0.23 | 0.14 | 0.10 | 0.14 | 0.13 | 0.12 | 0.12 |
| Leverage | ||||||||||
| Debt / Equity | 0.63 | 0.59 | 0.60 | 0.61 | 0.62 | 0.58 | 0.58 | 0.60 | 0.60 | 0.61 |
| Debt / Assets | 0.34 | 0.32 | 0.32 | 0.32 | 0.33 | 0.30 | 0.31 | 0.32 | 0.32 | 0.32 |
| Debt / EBITDA | 9.33 | - | 9.72 | 9.76 | 9.96 | - | - | - | 10.04 | - |
| Interest coverage | 8.4x | - | 7.9x | 7.8x | 7.3x | - | 6.6x | 6.5x | 7.0x | - |
| Equity multiplier | 1.88 | 1.88 | 1.87 | 1.91 | 1.91 | 1.91 | 1.89 | 1.89 | 1.89 | 1.91 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.19 | - | 0.19 | 0.19 | 0.19 | - | 0.19 | 0.20 | 0.19 | - |
| Inventory turnover | 0.42 | - | 0.41 | 0.44 | 0.44 | - | 0.45 | 0.49 | 0.45 | - |
| Days sales outstanding | 287d | - | 286d | 294d | 293d | - | 281d | 285d | 283d | - |
| Days inventory outstanding | 879d | - | 881d | 833d | 838d | - | 809d | 740d | 804d | - |
| Days payable outstanding | 147d | - | 166d | 163d | 155d | - | 166d | 143d | 148d | - |
| Cash conversion cycle | 1018d | - | 1002d | 964d | 976d | - | 923d | 882d | 939d | - |
| Valuation | ||||||||||
| P / E | 83.1x | - | 107.9x | 112.0x | 91.9x | - | 104.2x | 101.6x | 94.8x | - |
| P / B | 3.0x | - | 3.4x | 3.6x | 2.9x | - | 3.2x | 3.0x | 2.8x | - |
| P / S | 8.5x | - | 9.7x | 10.1x | 8.1x | - | 8.7x | 7.8x | 7.6x | - |
| EV / EBITDA | 53.7x | - | 63.9x | 66.7x | 55.6x | - | - | - | 55.3x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 11.1% | - | 5.0% | 2.7% | 2.0% | - | 7.9% | 7.8% | 4.2% | - |
| Revenue CAGR (3y) | 5.7% | - | 4.5% | 3.7% | 3.3% | - | 4.5% | 6.3% | 2.3% | - |
| Revenue CAGR (5y) | 3.9% | - | 5.0% | 5.1% | 2.3% | - | 4.3% | 3.5% | 2.1% | - |
| Gross profit growth (YoY) | 15.9% | - | 8.4% | 9.3% | 4.1% | - | 14.8% | 7.0% | 1.5% | - |
| Operating income growth (YoY) | 24.7% | - | 14.2% | 16.2% | 8.3% | - | 13.4% | -3.7% | -2.8% | - |
| Net income growth (YoY) | 28.2% | - | 13.0% | 21.5% | 11.4% | - | 3.6% | -9.1% | -8.1% | - |
| EPS growth (YoY) | 28.4% | - | 13.0% | 20.5% | 11.0% | - | 2.7% | -9.9% | -8.8% | - |
| EPS CAGR (3y) | 9.1% | - | 0.8% | -1.5% | -2.7% | - | -1.3% | 6.2% | -0.9% | - |
| EPS CAGR (5y) | 6.8% | - | 2.2% | 4.1% | 10.6% | - | 0.5% | -2.1% | -1.3% | - |
| FCF growth (YoY) | -64.0% | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | -23.0% | - |
| Book value growth (YoY) | 11.3% | 12.5% | 9.2% | 9.4% | 2.9% | 0.7% | 2.2% | 0.3% | 3.5% | 5.4% |
Peer comparison
Same SIC group: Industrial Organic Chemicals
Comparing SENSIENT TECHNOLOGIES CORP against the 5 most active filers in the same SIC group.
Dividends
$1.64/share trailing 12 months · 0.0% YoY
| Ex-date | Per share |
|---|---|
| May 11, 2026 | $0.4100 |
| Feb 3, 2026 | $0.4100 |
| Nov 10, 2025 | $0.4100 |
| Aug 4, 2025 | $0.4100 |
| May 12, 2025 | $0.4100 |
| Feb 4, 2025 | $0.4100 |
| Nov 4, 2024 | $0.4100 |
| Aug 5, 2024 | $0.4100 |
| May 3, 2024 | $0.4100 |
| Feb 5, 2024 | $0.4100 |
| Nov 3, 2023 | $0.4100 |
| Aug 4, 2023 | $0.4100 |
| May 5, 2023 | $0.4100 |
| Feb 6, 2023 | $0.4100 |
| Nov 4, 2022 | $0.4100 |
| Jul 29, 2022 | $0.4100 |
| May 6, 2022 | $0.4100 |
| Feb 1, 2022 | $0.4100 |
| Oct 29, 2021 | $0.4100 |
| Jul 30, 2021 | $0.3900 |
| Apr 30, 2021 | $0.3900 |
| Feb 1, 2021 | $0.3900 |
| Oct 30, 2020 | $0.3900 |
| Jul 31, 2020 | $0.3900 |